Full Text
EE373 Cost-Effectiveness of Statins, Ezetimibe and PCSK9 Inhibitor for Secondary Prevention of Cardiovascular Disease

Abstract

Authors

Y Xiang H Du L Gan S Li M Hu

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×